Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

Israel Cañadas(Fox Chase Cancer Center), David A. Barbie(Dana-Farber Cancer Institute), Rohit Thummalapalli(Memorial Sloan Kettering Cancer Center), Camilla L. Christensen(Dana-Farber Cancer Institute), Yanan Kuang(Dana-Farber Cancer Institute), Pablo Tamayo(Dana-Farber Cancer Institute), Kwok‐Kin Wong(NYU Langone Health), Hideo Watanabe(St. Catherine University), Marco Campisi(Dana-Farber Cancer Institute), Meenhard Herlyn(The Wistar Institute), Anika E. Adeni(Dana-Farber Cancer Institute), Diana Miao(Broad Institute), Shohei Koyama(Osaka City University), Russell W. Jenkins(Broad Institute), Masayuki Watanabe(MANI (Japan)), Ewa Sicińska(Harvard University), Brandon Piel(Dana-Farber Cancer Institute), Thanh U. Barbie(Brigham and Women's Hospital), Hideki Terai(Kitasato Institute Hospital), Lynnette Marie Sholl(Brigham and Women's Hospital), Debattama R. Sen(Harvard University), Jacob Sands(Harvard University), Cloud P. Paweletz(Massachusetts General Hospital), Shunsuke Kitajima(Japanese Foundation For Cancer Research), Tran C. Thai(Dana-Farber Cancer Institute), Scott J. Rodig(Brigham and Women's Hospital), Timothy Hagan(Dana-Farber Cancer Institute), Yu Imamura(Japanese Foundation For Cancer Research), Ravindra Uppaluri(Brigham and Women's Hospital), Gao Zhang(Central South University), Amir Reza Aref(Massachusetts General Hospital), Tian Tian(Qilu Hospital of Shandong University), Hideo Baba(Kaketsuken (Japan)), Yanxi Zhang(Dana-Farber Cancer Institute), Jong Wook Kim(University of California San Diego), Zhi Wei(New Jersey Institute of Technology), Christine Lydon(Dana-Farber Cancer Institute), Evisa Gjini(Brigham and Women's Hospital)
Nature Medicine
July 19, 2018
Cited by 317


Related Papers